KDM5B predicts temozolomide-resistant subclones in glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

KDM5B predicts temozolomide-resistant subclones in glioblastoma

Published:2024-01 Issue:1 Volume:27 Page:108596
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Ullrich Vivien,Ertmer Sarah,Baginska Anna,Dorsch Madeleine,Gull Hanah H.,Cima Igor,Berger Pia,Dobersalske Celia,Langer Sarah,Meyer Loona,Dujardin Philip,Kebir Sied,Glas Martin,Blau Tobias,Keyvani Kathy,Rauschenbach Laurèl,Sure Ulrich,Roesch Alexander,Grüner Barbara M.,Scheffler Björn

Funder

Deutsche Forschungsgemeinschaft

Deutschen Konsortium für Translationale Krebsforschung

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference60 articles.

1. A restricted cell population propagates glioblastoma growth after chemotherapy;Chen;Nature,2012

2. Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy;Lan;Nature,2017

3. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood;Weller;Nat. Rev. Clin. Oncol.,2021

4. Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity;Gimple;Nat. Rev. Cancer,2022

5. A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma;Kebir;Clin. Cancer Res.,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma;Cell Death Discovery;2024-05-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP